Wednesday, June 30, 2010

First Class of Boettcher Investigators Announced At Governor's Residence Ceremonies Today

The 2010 (Inaugural) Class of Boettcher Investigators in the Webb-Waring Biomedical Research Program includes the following:

* Shaodong Dai, Ph.D., Assistant Professor of Immunology, National Jewish Health, Chronic Beryllium Lung Disease

* Robin Dowell, D.Sc., Assistant Professor of Molecular, Cellular and Developmental Biology, University of Colorado at Boulder, Translational Bioinformatics Involving Drug Efficacy and Genetics

* Gidon Felsen, Ph.D., Assistant Professor of Physiology and Biophysics, University of Colorado – Anschutz Medical Campus, Parkinson’s Disease

* Paul Jedlicka, M.D., Ph.D., Assistant Professor of Pathology, University of Colorado – Anschutz Medical Campus, Ewing Sarcoma, a Common Cancer of the Bone and Soft Tissue Affecting Children

* Keith Neeves, Ph.D., Assistant Professor of Chemical Engineering, Colorado School of Mines, Role of Blood Flow in the Formation of Blood Clots

* Melissa Reynolds, Ph.D., Assistant Professor of Chemistry, Colorado State University, Nitric-Oxide Releasing Materials for Cardiovascular Medical Devices

Individual grant amounts for these research projects range from $200,000 to $300,000. The grant amounts allocated varied based on funding available to the institution and size of project. Per program guidelines, the minimum budget was required to be $200,000.

“We’d announced the creation of the Program in 2008, as the result of an innovative agreement among the Boettcher Foundation, Webb-Waring Foundation for Biomedical Research and the University of Colorado,” Tim Schultz, Boettcher Foundation President and Executive Director, explains. “In the interim, we’ve worked long and hard with our State’s Universities, public officials, the Governor’s Office, and the bioscience industry in Colorado to understand the strategies in place and to identify the best opportunity for investment by the Foundation of more than $1 million each year into efforts to increase our competitiveness in biomedical science.”

Link to the Business Wire Release

No comments:

Post a Comment